Asia Lifesciences Press Releaseshttp://www.asia-lifesciences.comAsia Lifesciences Press Releasesipmedia@intelligentpublishingmedia.comfrASP-PHPASP-PHPASP-PHP WebmasterCustom Tissue Sections & Microarrayshttp://www.asia-lifesciences.com/press_index.php?itemID=320 AMSBIO -AMS Biotechnology-custom acquisition-tissue sections GMTAmsbio offers services for custom acquisition, procurement and preparation of tissue sections andInovio Partner Announces Completion of Phase I DNA Vaccine Studyhttp://www.asia-lifesciences.com/press_index.php?itemID=319Inovio Biomedical Corporation -DNA vaccine design-Tripep AB -phase I GMTInovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development andIN Cell Image Competition 2009/2010 Voting Openshttp://www.asia-lifesciences.com/press_index.php?itemID=318GE Healthcare-IN Cell-- GMTGE Healthcare, a unit of General Electric Company (NYSE: GE), has opened voting for its annual INCollaborate on Human Genome Sequencing Projectshttp://www.asia-lifesciences.com/press_index.php?itemID=317Complete Genomics-GATC Biotech- Genome Sequencing-Human Genome GMTGATC Biotech and Complete Genomics, today announced the execution of a research collaborationActelion's miglustat in Niemann-Pick type C disease http://www.asia-lifesciences.com/press_index.php?itemID=316Actelion Ltd -new drug application-Zavesca-neurological manifestations GMTActelion Ltd (SIX: ATLN) announced today that a supplemental new drug application (sNDA) for an Novartis receives approval in Switzerland for CelturaŽ, a cell culture-based Influenza A(H1N1) pandemic vaccinehttp://www.asia-lifesciences.com/press_index.php?itemID=315 Novartis-Influenza A- cell culture-Celtura GMT FDA Discusses Neuromed NDA Application for Exalgohttp://www.asia-lifesciences.com/press_index.php?itemID=314Covidien-Exalgo- NDA -Neuromed GMT InterMune Announces Modification to On-Going Phase 2b Study of ITMN-191 in Patients with Chronic HCV Infectionhttp://www.asia-lifesciences.com/press_index.php?itemID=313 InterMune- Phase 2b-ITMN 191-Chronic HCV Infection GMT Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Dayhttp://www.asia-lifesciences.com/press_index.php?itemID=312 Boehringer Ingelheim- GlaxoSmithKline -EFA -COPD GMT Lonza expands cell-biology platformhttp://www.asia-lifesciences.com/press_index.php?itemID=311 The Lonza Group-cell biology-Simbiosys Biowares-molecular biology group GMTLonza Group (SIX:LONN) announces that it has completed the acquisition of the preclinical cell andInovio Biomedical CEO Introduces DNA Vaccine Potentialhttp://www.asia-lifesciences.com/press_index.php?itemID=310Inovio Biomedical -DNA Vaccine -World Knowledge Forum- GMTInovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development andJean-Jacques Bienaime to Receive Most Admired CEOhttp://www.asia-lifesciences.com/press_index.php?itemID=309 BioMarin Pharmaceutical Inc-Chief Executive -Jean Jacques Bienaime-Business Times GMTBioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that its Chief Executive Officer MediGene successfully completes patient recruitment into EndoTAGhttp://www.asia-lifesciences.com/press_index.php?itemID=308MediGene AG-EndoTAG-TM 1-Phase II GMTMediGene AG (Frankfurt: MDG, Prime Standard, TecDAX) has successfully completed patient